Skip to product information
1 of 1

Retatrutide (4-Pack)

Retatrutide (4-Pack)

Regular price $340.00 CAD
Regular price Sale price $340.00 CAD
Sale Sold out

In stock

  • Lab Tested for Purity & Quality
  • Fast & Secure Shipping
  • Manufactured in Canada
Size
Quantity

Buy Retatrutide in Canada | Research-Grade Triple Agonist Peptide

Diamond Peptides manufactures premium-quality Retatrutide for laboratories, research organizations, and wholesale distributors throughout Canada. Each vial contains lyophilized research-grade peptide produced under strict quality control standards and verified through High-Performance Liquid Chromatography (HPLC) purity testing together with Mass Spectrometry (MS) identity confirmation.

Developed for scientific investigation, Retatrutide is a synthetic triple-agonist peptide widely utilized in metabolic and receptor pharmacology research. Its unique biological profile has made it an increasingly valuable reference compound for modern peptide science. Whether you're sourcing material for university laboratories, contract research facilities, or commercial distribution, Diamond Peptides provides dependable Canadian-manufactured peptides backed by consistent quality, reliable inventory, and wholesale availability.

Product Details
  • Form: Lyophilized peptide
  • Net per vial: 10 mg (filled to approximately 104% of label)
  • Purity: ≥99% (HPLC-verified)
  • Identity: MS-verified (per COA)
  • Storage: 2–8 °C, protect from light
  • Formula / M.W.: C221H342N46O68 / 4728.8 Da
  • CAS: 2381089-83-2
What Makes Retatrutide a Unique Compound

Retatrutide differs from earlier incretin peptides through its ability to activate three separate metabolic receptors simultaneously. Traditional GLP-1 analogues target only the GLP-1 receptor, while newer dual agonists stimulate both GLP-1 and GIP receptors. Retatrutide expands upon this concept by incorporating glucagon receptor activity, enabling researchers to evaluate the combined effects of all three signalling pathways within a single experimental compound.

The peptide was originally developed by Eli Lilly under the research identifier LY3437943 and has progressed through multiple stages of clinical investigation. Findings from these studies have contributed to a growing body of peer-reviewed metabolic research. Although extensively studied, Retatrutide remains an investigational molecule and is supplied exclusively for laboratory research purposes.

Its engineered amino acid sequence is specifically designed to provide balanced receptor activation while incorporating structural modifications that improve peptide stability compared with naturally occurring incretin hormones. These enhancements make Retatrutide especially useful for long-term pharmacological and mechanistic investigations.

For researchers comparing metabolic peptide analogues, Retatrutide offers a valuable benchmark for understanding the specific contribution of glucagon receptor activation relative to single- and dual-receptor agonists. This has made it one of Diamond Peptides' most frequently requested compounds for multi-receptor signalling studies.

Key Benefits
  • Glucose & Insulin Signalling — Scientific publications have investigated Retatrutide's effects on glucose regulation and insulin secretion, with observed responses believed to result from coordinated GLP-1 and GIP receptor activation.
  • Energy Homeostasis — Both preclinical and clinical studies have examined the compound's influence on energy expenditure, metabolic efficiency, and body-weight regulation, where glucagon receptor activity represents an important variable of interest.
  • Liver & Lipid Research — Retatrutide has been investigated in hepatic metabolism research, including studies involving liver fat accumulation and lipid regulation, areas where glucagon signalling continues to attract significant scientific interest.
Related Research Peptides

Researchers commonly investigate Retatrutide alongside other metabolic research peptides, including:

Frequently Asked Questions

Where can I buy Retatrutide in Canada for laboratory research?

Diamond Peptides supplies research-grade Retatrutide exclusively for scientific use within Canada. Every production lot is accompanied by batch-specific documentation, including HPLC purity analysis, MS identity verification, and a Certificate of Analysis (COA).

How does Retatrutide compare with Tirzepatide or Semaglutide?

The key distinction is receptor activity. Semaglutide functions as a GLP-1 receptor agonist, while Tirzepatide activates both GLP-1 and GIP receptors. Retatrutide extends this mechanism further by engaging the glucagon receptor as well, making it a true triple-agonist peptide for advanced metabolic research.

Is Retatrutide naturally occurring?

No. Retatrutide is a fully synthetic peptide designed from naturally occurring incretin and glucagon hormone sequences. Strategic amino acid modifications improve molecular stability while maintaining balanced activity across all three receptor targets.

What is the recommended storage condition?

Lyophilized Retatrutide should be stored refrigerated between 2°C and 8°C and protected from light until use. Individual laboratories should follow their own validated handling and storage protocols throughout the research process.

⚠️ For research use only. Not intended for human or veterinary use. Not a drug, food, or supplement.

View full details